[1] ZHEN TAN . Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice[J]. Molecular and Cellular Endocrinology, 2017, 439: Pages 369-378. DOI:
10.1016/j.mce.2016.09.026[2] HAOSHU WU. Neohesperidin Exerts Lipid-Regulating Effects in vitro and in vivo via Fibroblast Growth Factor 21 and AMP-Activated Protein Kinase/Sirtuin Type 1/Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1α Signaling Axis.[J]. Pharmacology, 2017, 100 3-4: 115-126. DOI:
10.1159/000452492[3] JIA S, HU Y, ZHANG W, et al. Hypoglycemic and hypolipidemic effects of neohesperidin derived from Citrus aurantium L. in diabetic KK-Ay mice[J]. Food & Function, 2015, 3: 878-886. DOI:
10.1039/c4fo00993b